Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms.

Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. Abstract Text:

Hiroshi Tomoda,Satoshi Omura,

Diacylglycerol acyltransferase (DGAT) and acyl-CoA: cholesterol acyltransferase (ACAT) are the enzymes that catalyze the final reactions of triacylgycerol (TG) and cholesteryl ester (CE) synthesis, and accumulation of TG and CE in adipocytes and arteries causes obesity and atherosclerosis, respectively. Therefore, DGAT and ACAT have been viewed as potential therapeutic targets for these diseases. From the screening program for DGAT inhibitors, new compounds were discovered from fungal and plant extracts, and are expected to provide leads for drug development. From the screening programs for ACAT inhibitors and lipid droplet synthesis inhibitors, new compounds with chemical structures different from those of known synthetic inhibitors were discovered from the cultures of fungal and actinomycete strains. Among them, fungal beauveriolide III rather selectively inhibited ACAT1 isozyme, while fungal pyripyropene A was found to be a highly selective inhibitor of ACAT2 isozyme. Both inhibitors proved orally active in in vivo models. Furthermore, a library of beauveriolide and pyripyropene analogs was prepared by combinatorial and semisynthetic methods, respectively. The future prospects of these inhibitors are discussed.

Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. Publishing Authors By Initials

H Tomoda,S Omura,

For similar enzymes and coenzymes: enzymes: transferases: acyltransferases: sterol o-acyltransferase research abstracts see: enzymes and coenzymes: enzymes: transferases: acyltransferases: sterol o-acyltransferase research

PUBMED ID PMID:

MEDLINE DATE:

Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. Journal Published:

PUBLICATION TYPE: Review

Journal: Pharmacology & therapeutics

VOLUME: 115

Page Numbers: 375-89

Journal Abbreviation: Pharmacol. Ther.

ISSN: 0163-7258

DAY: 31

MONTH: 05

YEAR: 2007

Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7905840

Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. Keywords Mesh Terms:

KEYWORDS: Sterol O-Acyltransferase

MESH TERMS: antagonists & inhibitors

Chemical & Substance for Abstract: Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. Information

Substance Name: Sterol O-Acyltransferase

Registry Number: EC 2.3.1.26

Grant and Affiliation Information for Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms.

AFFILIATION: School of Pharmacy, Kitasato University, Tokyo, Japan. tomodah@pharm.kitasato-u.ac.jp

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pharmacol Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms Related Publications

• Acetanilide-hydrolyzing esterase of rat liver microsomes. I. Solubilization, purification, and intramicrosomal localization.
• Acetanilide-hydrolyzing esterase of rat liver microsomes. II. Turnover studies.
• Actinocatenispora sera sp. nov., isolated by long-term culturing.
• Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities.
• Biogenesis of endoplasmic reticulum membrane in rat liver cells. I. Intracellular sites of synthesis of cytochrome b5 and NADPH-cytochrome c reductase.
• Biogenesis of endoplasmic reticulum membrane in rat liver cells. II. Discharge of the nascent peptides of NADPH-cytochrome c reductase and cytochrome b5 on the cytoplasmic side of the endoplasmic reticulum membrane.
• Biogenesis of the mitochondrial matrix enzyme, glutamate dehydrogenase, in rat liver cells. I. Subcellular localization, biosynthesis, and intracellular translocation of glutamate dehydrogenase.
• Biogenesis of the mitochondrial matrix enzyme, glutamate dehydrogenase, in rat liver cells. II. Significance of binding of glutamate dehydrogenase to microsomal membrane.
• Bone with a vascular flap induced from fat tissue with the use of rhBMP-2 in rats.
• Design and synthesis via click chemistry of 8,9-anhydroerythromycin A 6,9-hemiketal analogues with anti-MRSA and -VRE activity.
• Different turnover behavior of phenobarbital-induced and normal NADPH-cytochrome c reductases in rat liver microsomes.
• Distribution of hepatic sulfite oxidase among subcellular organelles and its intraorganelle localization.
• Inhibition of 6-methylsalicyclic acid synthesis by the antibiotic cerulenin.
• Inhibition of the biosynthesis of leucomycin, a macrolide antibiotic, by cerulenin.
• Isolation and Structure Elucidation of Seco-neokadsuranic Acid A and 3,4-Seco-(24Z)-lanosta-4(30),8,24-triene-3,26-dioic Acid1.
• Isolation and structure elucidation of 12beta-acetoxycoccinic Acid, 12beta-hydroxycoccinic Acid, 12alpha-acetoxycoccinic Acid, and 12alpha-hydroxycoccinic acid1.
• Microbacterium sediminicola sp. nov. and Microbacterium marinilacus sp. nov., isolated from marine environments.
• Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms.
• Presence of apo-cytochrome beta 5 in microsomes from rat liver.
• Prevalence of Primary Aldosteronism: Should We Screen for Primary Aldosteronism before Treating Hypertensive Patients with Medication?
• Purification and Chemical Properties of Anti-complementary Polysaccharide from the Leaves of Artemisia princeps.
• Purification and properties of NADH-cytochrome b5 reductase solubilized by lysosomes from rat liver microsomes.
• Solubilization of NADH-cytochrome b5 reductase from liver microsomes by lysosomal digestion.
• Stability of messenger RNA's for microsomal NADPH-cytochrome c reductase and cytochrome b 5 in the livers of normal and phenobarbital-treated rats.
• Structural Characterization of Anti-Complementary Polysaccharides from the Leaves of Artemisia princeps.
• Subfractionation of rat liver microsomes by immunoprecipitation and immunoadsorption methods.
• The early stage of labeling of microsomal membrane proteins in rat liver by radioactive amino acids.
• The nucleases from Acrocylindrium sp. I. Purification and properties of ribonuclease.
• Triterpenoid Acids from Kadsura longipedunculata. Neokadsuranic Acids B and C: Two Novel Triterpenoids with 14 (13 --> 12)abeo-Lanostane Skeletons.
• Yemuoside YM7, YM11, YM13, and YM14: Four Nortriterpenoid Saponins from Stauntonia chinensis.